Storys aus Boston

Servier

Servier to Acquire Agios Pharmaceuticals' Oncology Business

Paris and Boston (ots/PRNewswire) - - Transaction includes commercial, clinical and research-stage oncology portfolio and employees for up to $2 billion plus royalties - Includes Agios' marketed medicine TIBSOVO® and a strong oncology pipeline of Phase 3 and early-stage assets - Acquisition in-line with Servier's strategic ambition to become a recognized and innovative player in oncology, supported by unique drug ...

China Matters

China Matters documents traditional and modern cultures of Tianjin

Beijing (ots/PRNewswire) - When comes to a Chinese city that resembles Boston, quite a few netizens would name Tianjin, a city blending modern vibe with traditional heritage. Ranked the third largest urban land area after Beijing and Shanghai, Tianjin created a uniquely compatible urban style, Chinese and Western, ancient and modern, making the best use of its 600 ...

Sophia Genetics

Bram Goorden joins SOPHiA GENETICS as Chief Commercial Officer and Head of North America

Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Bram Goorden joined its Executive team, holding the dual role of Chief Commercial Officer and Head of North America. Goorden comes to SOPHiA from Foundation Medicine Inc. (Cambridge, MA) where he held the role of VP of International Business and ...

5GAA - 5G Automotive Association e.V.

5G Automotive Association Virtual Showcase Highlights Momentum behind C-V2X Technology Deployment for Connected Vehicles and Smart Cities in the U.S.

Sophia Genetics

SOPHiA GENETICS Raises $110 Million in Oversubscribed New Funding Round

Lausanne, Switzerland and Boston (ots/PRNewswire) - Supporting the Company's Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine - SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader - Company ...

MSD Merck Sharp & Dohme AG

MSD (Merck Sharp & Dohme AG) Switzerland appoints Ans Heirman, Ph.D. as the new Managing Director of MSD Switzerland, effective September 1st, 2020

Merck Healthcare Germany

Stephan Sieber Awarded EUR 1 Million Future Insight Prize 2020 by Merck

Darmstadt, Germany (ots/PRNewswire) - - Prof. Sieber is developing approaches against multi-resistant pathogens at the Technical University of Munich - Inaugural Johann Anton Merck Award presented to Prof. Caroline Dive, Cancer Research UK, for her liquid biopsy research - Sibel Health awarded the Nature Spinoff Prize Merck, a leading science and technology company, ...

Sophia Genetics

SOPHiA GENETICS Expands Its Executive Team, Naming Lara Hashimoto Chief Business Officer

Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief Business Officer, effective April 1st. She will be responsible for Marketing, Product Management and Business Development. Lara Hashimoto joined the healthcare industry 20 years ago holding ...

Sophia Genetics

SOPHiA GENETICS and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic

Lausanne, Switzerland, and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering ...

ArisGlobal

ArisGlobal to Co-Present "Enhancing Operations: Enabling Digital Transformation With Next-Gen Technology" at World Drug Safety Congress Americas

Miami (ots/PRNewswire) - ArisGlobal, a leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, is thrilled to announce their participation at the World Drug Safety Congress Americas 2020 ...

Sophia Genetics

SOPHiA GENETICS' Board of Directors Elects Troy Cox as New Chairman

Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that former Foundation Medicine CEO Troy Cox has been elected as Chairman of the Board of Directors, effective March 1, 2020. He is replacing Antoine Duchateau, who has served as chairman since 2013 and will continue as a board member. Cox joined the ...

X-Technology Swiss R&D AG

2

PUMA AND X-BIONIC® CREATE TOGETHER A HIGHLY-FUNCTIONAL COLLECTION OF PRODUCTS

Grünenthal Group

Jan Adams Appointed Chief Scientific Officer for Grünenthal

Aachen, Germany (ots/PRNewswire) - Grünenthal announced today that Jan Adams, MD has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board effective 1 January 2020. Since July 2019, Jan has already served as acting CSO, leading the strategic re-alignment of Grünenthal's R&D organisation. Jan brings over 15 years of experience in healthcare and the biopharmaceutical industry. He joined ...

Andrew Alliance SA

Andrew Alliance Announces Partnership With Brooks Life Sciences Enabling Their Consumables to be Added to Its Groundbreaking OneLab Software

Geneva (ots/PRNewswire) - Andrew Alliance and Brooks Life Sciences today announced a co-marketing relationship that will enable Brooks Life Sciences consumables to be added to Andrew Alliance's groundbreaking OneLab software environment, developed to support the design, execution and sharing of life science ...

UCB Pharma

UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases

- Will enhance UCB's leadership potential in myasthenia gravis by adding zilucoplan, a peptide inhibitor of complement component 5 (C5) currently in phase 3, to the UCB pipeline alongside to UCB's rozanolixizumab, an FcRn targeting antibody also in phase 3 - Will enrich UCB's pipeline; zilucoplan is a novel, ...

Deutsche Finance America

Deutsche Finance America Announces $1.5 Billion of Closed U.S. Investments in First Year

Following JV Equity Investments in New York, Beverly Hills, South Beach Miami, Boston, Boulder, and Minneapolis, Looks to Build on Success of Multi-Market, Multi-Sector Investment Strategy Denver (ots/PRNewswire) - Deutsche Finance America ("DFA") is pleased to celebrate its first anniversary, following the establishment of the U.S. real estate private equity ...

Sophia Genetics

SOPHiA GENETICS Expands Executive Team With a Chief Marketing Officer and New Chief Information Officer

Lausanne, Switzerland, and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Gaëtan Fraikin and Sergei Yakneen have joined its executive team as Chief Marketing Officer and Chief Information Officer, respectively. Mr. Fraikin and Mr. Yakneen bring decades of highly ...

Bucher + Suter

Bucher + Suter and NovelVox Join Forces to Expand Cisco Contact Center Integrations and Enhance the Customer Experience

Boston (ots/PRNewswire) - Bucher + Suter and NovelVox are delighted to announce their new global partnership, which will expand both companies' reach across the Cisco Contact Center integration solutions landscape. Under the terms of the OEM agreement, Bucher + Suter will use NovelVox's technology for the Cisco ...

Greater Zurich Area AG

Greater Zurich Area appoints Honorary Ambassadors for the global promotion of Zurich as a technology and business location

Schweizerischer Nationalfonds / Fonds national suisse

Photography: A fresh look at science

Bern (ots) - The 457 entries submitted to the third SNSF Scientific Image Competition jury are online. They offer a behind-the-scenes look at research through stunning images and intriguing videos. The international jury awarded prizes to 15 entries that will be exhibited at the Biel/Bienne Festival of Photography. Now in its third edition, the SNSF Scientific Image Competition has collected more than 1200 photographs and ...

Merck Healthcare Germany

Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

Not intended for US, Canada and UK-based media Darmstadt, Germany and New York (ots/PRNewswire) - - JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for ...

Merck Healthcare Germany

Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors

Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Exclusive license grants Vertex one clinical and one pre-clinical DNA-PK inhibitor for use in gene-editing applications in six specific genetic disease areas - Merck retains the rights to both compounds in all other disease areas, including oncology - Merck retains the rights to utilize and ...

Sophia Genetics

SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine

San Francisco (ots/PRNewswire) - SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest ...

Greater Zurich Area AG

Greater Zurich Area appoints Honorary Ambassadors on the East Coast